Celebrate Two Years of RSC Pharmaceutics with Us!
In April 2024, RSC Pharmaceutics launched its very first issue. Since then, we’ve featured a range of striking and creative cover images that reflect the exciting research published in the journal.
We invite you to help us celebrate by voting for your favourite cover from our first year.
Vote for your favourite cover here
 |
 |
 |
| A zuranolone nanocrystal formulation enables solubility-independent in vivo study of pentylenetetrazol-induced seizures in a rat model | Electrostatically hindered diffusion for predictable release of encapsulated cationic antimicrobials | A model binary system for the evaluation of novel ion pair formulations of diclofenac |
| Stanislav Chvíla, Hana Kubová, Pavel Mareš, Eva Kudová and František Štěpánek | Viktor Eriksson, Erik Nygren, Romain Bordes, Lars Evenäs and Markus Andersson Trojer | Mignon Cristofoli, Jonathan Hadgraft, Majella E. Lane and Bruno C. Sil |
| RSC Pharm., 2024,1, 37-46
|
RSC Pharm., 2024,1, 47-56
|
RSC Pharm., 2024,1, 234-244
|
 |
 |
 |
| Enhancement of drug permeation across skin through stratum corneum ablation | Green synthesis of silver nanoparticles using Phyllanthus emblica extract: investigation of antibacterial activity and biocompatibility in vivo | Polymer–drug conjugates as nano-sized multi-targeting systems for the treatment of Alzheimer’s disease |
| Ayyah Abdoh, David Liu and Yousuf Mohammed | Md Monir Hossain, Amir Hamza, Shakil Ahmed Polash, Mehedi Hasan Tushar, Masato Takikawa, Anuj Bhowmik Piash, Chaitali Dekiwadia, Tanushree Saha, Shinji Takeoka and Satya Ranjan Sarker | Nuruddin Mahadik, Gemma A. Barron, Paul Kong Thoo Lin and Colin J. Thompson |
| RSC Pharm., 2024,1, 151-160
|
RSC Pharm., 2024,1, 245-258
|
RSC Pharm., 2024,1, 161-181
|
 |
 |
 |
| Doxorubicin-Polysorbate 80 conjugates: targeting effective and sustained delivery to the brain | Is receptor mediated active macrophage targeting of amphotericin B nanoformulations a promising approach? | Programmable protein delivery from microgel/hydrogel composites (MHCs) via discrete combinations of multi-state protein-loaded unit ingredients |
| S. Ram Prasad, Sruthi Sudheendran Leena, Ani Deepthi, A. N. Resmi, Ramapurath S. Jayasree, K. S. Sandhyab and A. Jayakrishnan | Saugandha Das, Pooja Todke, Manisha Madkaikar and Padma Devarajan | Longfei Chen and Saif A. Khan |
| RSC Pharm., 2024,1, 412-429
|
RSC Pharm., 2024,1, 430-440
|
RSC Pharm., 2024,1, 689-704
|
 |
 |
 |
| Pharmaceutical salts of azole anti-fungal drugs: physicochemical behaviour and activity studies | Prodrug nanotherapy demonstrates in vivo anticryptosporidial efficacy in a mouse model of chronic Cryptosporidium infection | Structure–activity relationships of DNA nanocarriers based on the amphipathic cell penetrating peptide transportan 10 |
| Hafsa Qadri, Asif A. Malik, Aadil A. Ahangar, Manzoor Ahmad Mir, Ajiaz A. Dar and Abdul Haseeb Shah | Amalendu P. Ranjan, Daniel J. Czyzyk, Griselle Martinez-Traverso, Aygul Sadiqova, Margarita Valhondo, Deborah A. Schaefer, Krasimir A. Spasov, William L. Jorgensen, Jamboor K. Vishwanatha, Michael W. Riggs, Alejandro Castellanos-Gonzalez and Karen S. Anderson | Lucas Rodrigues de Mello, Tâmisa Seeko Bandeira Honda, Sang Won Han, Valeria Castelletto, Ian William Hamley, Ly Porosk, Ülo Langel and Emerson Rodrigo da Silva |
| RSC Pharm., 2024,1, 705-715 | RSC Pharm., 2024,1, 963-975 | RSC Pharm., 2024,1, 976-993 |